Shufro Rose & CO LLC Mckesson Corp Transaction History

Shufro Rose & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$300.57 - $336.42 $210,399 - $235,494	-700 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$244.61 - $310.48 $489,220 - $620,960	-2,000 Reduced 74.07%	700 $214,000
Q2 2019 Jul 24, 2019	BUY	$112.47 - $134.93 $303,669 - $364,311	2,700 New	2,700 $363,000
Q1 2019 May 03, 2019	SELL	$111.86 - $136.3 $78,302 - $95,410	-700 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$108.23 - $136.84 $281,398 - $355,784	-2,600 Reduced 78.79%	700 $77,000
Q3 2018 Oct 26, 2018	BUY	$123.14 - $138.52 $12,314 - $13,852	100 Added 3.13%	3,300 $438,000
Q2 2018 Jul 27, 2018	BUY	$133.4 - $158.13 $426,880 - $506,016	3,200 New	3,200 $427,000

1,753

111M

871K

902K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $78.8B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.